Application of a Bayesian method to monitor and adjust vancomycin dosage regimens
- 1 June 1990
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 34 (6) , 1165-1171
- https://doi.org/10.1128/aac.34.6.1165
Abstract
A Bayesian method for monitoring vancomycin concentrations and adjusting regimens in patients with unstable renal function by using a two-compartment population model was evaluated with a personal computer. The population model was derived from data from 12 cardiac outpatients who received single doses of vancomycin. The performance of the method was then tested in 27 acutely ill patients who received multiple doses of vancomycin. Significant renal impairment was observed in 15 patients. Renal function changed in 15 patients. The vancomycin concentrations in the patients with changing renal function were not at steady state during the observation times. Two concentrations in serum (peak and then trough, or trough and then peak) were fitted along with the population model to individualize the parameter values for each patient. All the subsequent concentrations in serum for each patient were then predicted by using the parameter values for each patient. Future concentrations of 118 serum samples were predicted. The mean absolute prediction error was 3.6 +/- 4.5 micrograms/ml, and the mean prediction error was -0.7 +/- 5.3 micrograms/ml. These results confirm that a two-compartment pharmacokinetic model can be sufficiently individualized with the knowledge of just two concentrations of drug in patient serum; it is possible to predict closely subsequent concentrations in serum, and dosing regimens for individual patients can be well adjusted to achieve the chosen therapeutic goals.This publication has 25 references indexed in Scilit:
- Evaluation of a Two-Compartment Bayesian Forecasting Program for Predicting Vancomycin ConcentrationsTherapeutic Drug Monitoring, 1989
- Bacteremia in patients undergoing oral procedures. Study following parenteral antimicrobial prophylaxis as recommended by the American Heart Association, 1977Archives of internal medicine (1960), 1988
- Comparison of steady-state pharmacokinetics of two dosage regimens of vancomycin in normal volunteersAntimicrobial Agents and Chemotherapy, 1987
- Pharmacokinetics of vancomycin in patients with various degrees of renal functionAntimicrobial Agents and Chemotherapy, 1984
- Pharmacokinetics of vancomycin: observations in 28 patients and dosage recommendationsAntimicrobial Agents and Chemotherapy, 1982
- Optimal sampling times for pharmacokinetic experimentsJournal of Pharmacokinetics and Biopharmaceutics, 1981
- Some suggestions for measuring predictive performanceJournal of Pharmacokinetics and Biopharmaceutics, 1981
- Single‐Dose Kinetics of Intravenous VancomycinThe Journal of Clinical Pharmacology, 1980
- A program package for simulation and parameter estimation in pharmacokinetic systemsComputer Programs in Biomedicine, 1979
- RENAL EXCRETION OF VANCOMYCIN IN KIDNEY DISEASEActa Medica Scandinavica, 1975